Back
Stoke Therapeutics, Inc. 10K Form
Buy
66
STOK
Stoke Therapeutics, Inc.
Last Price:
$31.06
Seasonality Move:
14.31%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive STOK News And Ratings
See the #1 stock for the next 7 days that we like better than STOK
STOK Financial Statistics
Sales & Book Value
| Annual Sales: | $36.6M |
|---|---|
| Cash Flow: | $-30.5M |
| Price / Cash Flow: | 34.5 |
| Annual Sales: | $5.59 |
| Price / Book: | 5.74 |
Profitability
| EPS (TTM): | 0.65990 |
|---|---|
| Net Income (TTM): | $40.6M |
| Gross Margin: | $32.1M |
| Return on Equity: | 13.95% |
| Return on Assets: | 11.82% |
Stoke Therapeutics, Inc. Earnings Forecast
Key Stoke Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 8 years for STOK is 87.85%.
-
The Selling, General & Administrative Expenses for STOK have been equal to 133.48% of Gross Profit Margin.
-
The Research & Development expenses have been 237.88% of Revenue.
-
The Net Earning history of STOK is -243.42% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 3 years.
Stoke Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | STOK |
| CUSIP: | 86150R |
| Website: | stoketherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 6.53 |
| Quick Ratio: | 6.17 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
STOK Technical Analysis vs Fundamental Analysis
Buy
66
Stoke Therapeutics, Inc. (STOK)
is a Buy
Is Stoke Therapeutics, Inc. a Buy or a Sell?
-
Stoke Therapeutics, Inc. stock is rated a BuyThe current Stoke Therapeutics, Inc. [STOK] share price is $31.05. The Score for STOK is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.